Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Keio University Health Center, Tokyo, Japan.
BMC Pulm Med. 2018 Jul 13;18(1):114. doi: 10.1186/s12890-018-0686-5.
Pulmonary Mycobacterium avium complex (pMAC) disease is a chronic, slowly progressive disease. The aim of the present study was to determine the association of six-minute walk test (6MWT) parameters with pulmonary function and the health-related quality of life (HRQL) in patients with pMAC disease.
This cross-sectional study included adult patients with pMAC and was conducted at Keio University Hospital. We investigated the relationship of 6MWT parameters with clinical parameters, including pulmonary function, and HRQL, which was assessed using the 36-Item Short Form Health Survey (SF-36) and St. George's Respiratory Questionnaire (SGRQ).
In total, 103 consecutive patients with pMAC participated in 6MWT (median age, 64 years; 80 women) and completed SF-36 and SGRQ. The six-minute walk distance (6MWD) showed significant negative and positive correlations with all SGRQ domain scores [ρ = (- 0.54)-(- 0.32)] and the physical component summary (PCS) score (ρ = 0.39) in SF-36, respectively; the opposite was observed for the final Borg scale (FBS) score (all SGRQ scores, ρ = 0.34-0.58; PCS score, ρ = - 0.50). The distance-saturation product showed significant negative and positive correlations with all SGRQ scores [ρ = (- 0.29)-(- 0.55)] and the PCS score (ρ = 0.40), respectively. Multivariate analysis revealed that 6MWD and the FBS score were significant predictors of HRQL.
Our findings suggest that 6MWD and the FBS score are useful parameters for evaluating HRQL in patients with pMAC. Further studies should investigate the impact of 6WMT parameters on disease progression, treatment responses, and prognosis.
肺鸟分枝杆菌复合群(pMAC)病是一种慢性、进展缓慢的疾病。本研究旨在确定 6 分钟步行试验(6MWT)参数与 pMAC 患者的肺功能和健康相关生活质量(HRQL)之间的关系。
这是一项在庆应义塾大学医院进行的成人 pMAC 患者的横断面研究。我们调查了 6MWT 参数与临床参数的关系,包括肺功能和 HRQL,HRQL 通过 36 项简短健康调查(SF-36)和圣乔治呼吸问卷(SGRQ)进行评估。
共有 103 例连续的 pMAC 患者参加了 6MWT(中位年龄 64 岁;80 名女性)并完成了 SF-36 和 SGRQ。6 分钟步行距离(6MWD)与所有 SGRQ 域评分呈显著负相关[ρ=(-0.54)-(-0.32)]和 SF-36 的生理成分综合评分(PCS)评分(ρ=0.39);与最终 Borg 量表(FBS)评分呈正相关(所有 SGRQ 评分,ρ=0.34-0.58;PCS 评分,ρ=-0.50)。距离饱和度乘积与所有 SGRQ 评分呈显著负相关[ρ=(-0.29)-(-0.55)]和 PCS 评分(ρ=0.40)。多变量分析显示,6MWD 和 FBS 评分是 HRQL 的显著预测因子。
我们的研究结果表明,6MWD 和 FBS 评分是评估 pMAC 患者 HRQL 的有用参数。需要进一步的研究来探讨 6WMT 参数对疾病进展、治疗反应和预后的影响。